Creekmur Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MMEA
Creekmur Asset Management's ARKG Position: Q3 2024 in Review
Creekmur Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 1 share — an estimated $23 sold.
Creekmur Asset Management first reported a position in ARKG in Q4 2023 and held it in 3 quarters. The position peaked at $33 in Q4 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.
- Creekmur Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
- Creekmur Asset Management sold 1 ARK Genomic Revolution ETF share in Q3 2024, an estimated $23.
- Creekmur Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 3 quarters.
- Creekmur Asset Management's ARK Genomic Revolution ETF position peaked at $33 in Q4 2023.
- 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.
Based on Creekmur Asset Management's 13F filing for Q3 2024, filed 25 Oct 2024.